| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| €5.168 | 43.24% | ||
| €5.168 | 43.24% | ||
| €3.608 | 7.8% | ||
| €3.608 | 7.8% | ||
| €3.347 | -10.27% | ||
| €3.73 | |||
| €0.086 | -82.48% | ||
| €0.491 | -43.98% | ||
| €0.8764 | |||
| €0.02 | 100% | ||
| €0.01 | 0% | ||
| €0.01 | -80% | ||
| €0.05 | 0% | ||
Allianz Biotechnologie A pays a dividend yield (FWD) of 2.30%.
- ISIN
- WKN
- Symbol / Exchange
- / XFRA
- Value
- €224.67
- Dividend frequency
- annually
- Security Type
- Fund
- Dividend Currency
- Euro
- 8 Countries
United States
93.31%United Kingdom
2.49%Denmark
1.73%France
0.68%Canada
0.64%Netherlands
0.51%Singapore
0.50%Switzerland
0.14%
- 1 Sector
Health Care
100.00%
- 10 Holdings
- Gilead Sciences Inc9.06%
- Amgen Inc8.20%
- Insmed Inc3.28%
- argenx SE ADR2.57%
- Illumina Inc1.64%
Similar securities
Those who hold Allianz Biotechnologie A often invest in these securities as well.
- Within the last 12 months, Allianz Biotechnologie A paid a dividend of €5.17. For the next 12 months, Allianz Biotechnologie A is expected to pay a dividend of €5.17. This corresponds to a dividend yield of approximately 2.30%.
- The dividend yield of Allianz Biotechnologie A is currently 2.30%.
- Allianz Biotechnologie A pays annually dividends. Payout is in March.
- The next dividend for Allianz Biotechnologie A is expected in March.
- Within the last 10 years, Allianz Biotechnologie A has paid dividends in 7 of them.
- Dividends of €5.17 are expected for the next 12 months. This corresponds to a dividend yield of 2.30%.
- The largest sectors of Allianz Biotechnologie A are Health Care.
- There are currently no known stock splits for Allianz Biotechnologie A.
- To receive the last dividend of Allianz Biotechnologie A on 4 March 2026 in the amount of €5.17 you had to have the stock in your portfolio before the ex-day on 2 March 2026.
- The last dividend was paid on 4 March 2026.
- In 2022, no dividends were paid by Allianz Biotechnologie A.
- Dividends from Allianz Biotechnologie A are paid in Euro.
- In Allianz Biotechnologie A, the United States, the United Kingdom and Denmark are represented as the three largest countries.

